Related Experiment Video
Updated: Jun 20, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Clinical approach to lupus nephritis: recent advances
C Molino1, F Fabbian, C Longhini
1Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, Italy. clinicamedica@unife.it
Systemic lupus erythematosus (SLE) frequently affects the kidneys, leading to lupus nephritis. Early detection and treatment are crucial for improving patient prognosis, despite complex and potentially toxic therapies.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Kidney involvement, or lupus nephritis, is a common complication of systemic lupus erythematosus (SLE).
- Clinical and histological manifestations of lupus nephritis are highly variable, even in asymptomatic patients.
- The International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 classification aimed to standardize lupus nephritis diagnosis.
Purpose of the Study:
- To review the current understanding of lupus nephritis in SLE.
- To highlight the importance of the ISN/RPS 2003 classification for lupus nephritis.
- To discuss current and emerging treatment strategies for lupus nephritis.
Main Methods:
- Review of existing literature on lupus nephritis in SLE.
- Analysis of the ISN/RPS 2003 classification criteria.
- Discussion of current therapeutic approaches and their toxicities.
Main Results:
- Most SLE patients exhibit histological evidence of lupus nephritis, often before clinical symptoms appear.
- The ISN/RPS 2003 classification improves diagnostic clarity and reproducibility for lupus nephritis.
- Treatment, while effective, involves complex and potentially toxic regimens including corticosteroids and immunosuppressants like cyclophosphamide, azathioprine, or mycophenolate mofetil.
Conclusions:
- Regular patient monitoring is essential for early detection of kidney involvement in SLE.
- Timely diagnosis and management of lupus nephritis significantly improve patient outcomes.
- Ongoing research into less toxic and more effective immunosuppressive agents is critical for SLE management.
More Related Videos
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome I : Introduction
Acute Pyelonephritis I: Introduction
